
Sign up to save your podcasts
Or


Dr. Pascal Hilliquin, who is Head of the Rheumatology Department at the Central Hospital of Southern Paris in Corbeil-Essonnes in France, is joining "Let's Talk OA" to talk about how NSAIDs recommendations change in the short, mid and long term scenarios as well as in the earlier stages of OA. Although each patient should always be analysed individually, there are many general aspects you won't want to miss. Dr. Hilliquin will be joining us on another episode so stay tuned for more.
By Laboratoires ExpanscienceDr. Pascal Hilliquin, who is Head of the Rheumatology Department at the Central Hospital of Southern Paris in Corbeil-Essonnes in France, is joining "Let's Talk OA" to talk about how NSAIDs recommendations change in the short, mid and long term scenarios as well as in the earlier stages of OA. Although each patient should always be analysed individually, there are many general aspects you won't want to miss. Dr. Hilliquin will be joining us on another episode so stay tuned for more.